Use of Study Data. Subject to the other provisions of this Agreement, Institution and Principal Investigator shall have the right to use such Study Data for its own internal non- commercial research, teaching and Study subject treatment purposes, and for publications, presentations and public disclosures in accordance with Section 8.0. 9.3 Použití údajů o studii. Při dodržení ostatních ustanovení této smlouvy budou mít zdravotnické zařízení a hlavní zkoušející právo použít tyto údaje o studii pro účely svého interního nekomerčního výzkumu, výuky a léčby subjektů studie, v publikacích a prezentacích a při zveřejnění informací v souladu s odstavcem 8.0.
Use of Study Data. Institution will have the non-exclusive right to use Study Data (i) subject to the obligations set forth in section 3 “Confidentiality”, for internal, non-commercial research and for educational purposes, and (ii) for preparation of publications in accordance with Section 5 “Publication Rights”.
Use of Study Data. University agrees to comply with all applicable state and federal laws and regulations, including the Health Insurance Portability and Accountability Act of 1996, as codified at 42 U.S.C. § 1320d (“HIPAA”) and any current and future regulations promulgated thereunder. Both parties agree that the use of data generated under this Study shall be governed by the terms and conditions of the Informed Consent and HIPAA authorization forms, which have been or will be approved by University’s IRB. Terms and conditions of this Agreement shall not supersede or modify the use of data terms and conditions listed in the Informed Consent and HIPAA authorization forms. Principal Investigator will ensure that the requirements relating to and obtaining Informed Consent and IRB review and approval are met.
Use of Study Data. (a) Use of a Party’s Own Study Data. Novartis may use and analyze the Novartis Study Data for any purpose without obligation or accounting to Olema, who shall hold the Novartis Study Data in confidence pursuant to this Agreement. Olema may use and analyze Olema Study Data for any purpose without obligation or accounting to Novartis, who shall hold Olema Study Data in confidence pursuant to this Agreement.
Use of Study Data. Site may use Study Data in connection with Study Subject care and for internal, non-commercial research purposes subject to the terms of this Agreement including Section 5 “Publication Rights”. 1.3.4
Use of Study Data. (a) EQRx may use and analyze the EQRx Study Data for any purpose without obligation or accounting to TPT, who will hold the EQRx Study Data in confidence pursuant to this Agreement. TPT may use and analyze TPT Study Data for any purpose without obligation or accounting to EQRx, who will hold TPT Study Data in confidence pursuant to this Agreement. Further, EQRx shall have the right to [***]. [***] = Certain Confidential Information Omitted
Use of Study Data. Subject to the other provisions of this Agreement, Service Provider shall have the right to use such Study Data for its own internal non- commercial research, teaching and Study subject treatment purposes, and for 9.3 Použití údajů o studii. Při dodržení ostatních ustanovení této smlouvy bude mít poskytovatel služeb právo použít takové údaje o studii pro účely svého interního nekomerčního výzkumu, výuky a léčby subjektů studie, v publikacích publications, presentations and public disclosures in accordance with Section 8.0. a prezentacích a při zveřejnění informací v souladu s článkem 8.0.
Use of Study Data. Corporation acknowledges that Institution owns the Study Data; provided, that Corporation is hereby granted an irrevocable, perpetual royalty-free right to receive and use all Study Data, except for the disclosure of subject-identifying information, for any business purpose it deems appropriate, including, without limitation, for submission to any governmental or regulatory agencies, domestic or foreign. Institution shall promptly disclose to Corporation all Study Data.
Use of Study Data. (a) Use of a Party’s Own Study Data. Each Party may use and analyze its own Study Data for any purpose without obligation or accounting to the other. *** INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. EXECUTION VERSION
Use of Study Data. Company shall have the unrestricted right to freely use all Study Data that it receives hereunder in whatever manner it desires, subject to Section 6.1. The process and timing for disclosure of Study Data to Company are described in the Study Data Use and Publication Guidelines attached as Exhibit C (the “Data Guidelines”).
